Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study

2014294 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Neurology

Volume 13, Issue 10, pp. 987-996

Field-Weighted Citation Impact: 22.18